129 related articles for article (PubMed ID: 10896673)
1. Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release.
Achenbach TV; Müller R; Slater EP
J Biol Chem; 2000 Oct; 275(41):32089-97. PubMed ID: 10896673
[TBL] [Abstract][Full Text] [Related]
2. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism.
Pei XY; Dai Y; Grant S
Mol Cancer Ther; 2004 Dec; 3(12):1513-24. PubMed ID: 15634644
[TBL] [Abstract][Full Text] [Related]
3. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway.
Alonso M; Tamasdan C; Miller DC; Newcomb EW
Mol Cancer Ther; 2003 Feb; 2(2):139-50. PubMed ID: 12589031
[TBL] [Abstract][Full Text] [Related]
4. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.
Byrd JC; Shinn C; Waselenko JK; Fuchs EJ; Lehman TA; Nguyen PL; Flinn IW; Diehl LF; Sausville E; Grever MR
Blood; 1998 Nov; 92(10):3804-16. PubMed ID: 9808574
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
[TBL] [Abstract][Full Text] [Related]
6. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
[TBL] [Abstract][Full Text] [Related]
7. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria.
Yu W; Sanders BG; Kline K
Cancer Res; 2003 May; 63(10):2483-91. PubMed ID: 12750270
[TBL] [Abstract][Full Text] [Related]
8. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl.
Anto RJ; Mukhopadhyay A; Denning K; Aggarwal BB
Carcinogenesis; 2002 Jan; 23(1):143-50. PubMed ID: 11756235
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
Rashmi R; Kumar S; Karunagaran D
Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
[TBL] [Abstract][Full Text] [Related]
10. Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calcium.
Hussain SR; Lucas DM; Johnson AJ; Lin TS; Bakaletz AP; Dang VX; Viatchenko-Karpinski S; Ruppert AS; Byrd JC; Kuppusamy P; Crouser ED; Grever MR
Blood; 2008 Mar; 111(6):3190-9. PubMed ID: 18192508
[TBL] [Abstract][Full Text] [Related]
11. Flavopiridol induces mitochondrial-mediated apoptosis in murine glioma GL261 cells via release of cytochrome c and apoptosis inducing factor.
Newcomb EW; Tamasdan C; Entzminger Y; Alonso J; Friedlander D; Crisan D; Miller DC; Zagzag D
Cell Cycle; 2003; 2(3):243-50. PubMed ID: 12734434
[TBL] [Abstract][Full Text] [Related]
12. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway.
Decker RH; Dai Y; Grant S
Cell Death Differ; 2001 Jul; 8(7):715-24. PubMed ID: 11464216
[TBL] [Abstract][Full Text] [Related]
13. Different pathways mediate cytochrome c release after photodynamic therapy with hypericin.
Vantieghem A; Xu Y; Declercq W; Vandenabeele P; Denecker G; Vandenheede JR; Merlevede W; de Witte PA; Agostinis P
Photochem Photobiol; 2001 Aug; 74(2):133-42. PubMed ID: 11547546
[TBL] [Abstract][Full Text] [Related]
14. Flavopiridol potently induces small cell lung cancer apoptosis during S phase in a manner that involves early mitochondrial dysfunction.
Litz J; Carlson P; Warshamana-Greene GS; Grant S; Krystal GW
Clin Cancer Res; 2003 Oct; 9(12):4586-94. PubMed ID: 14555534
[TBL] [Abstract][Full Text] [Related]
15. Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax.
Kim TH; Zhao Y; Barber MJ; Kuharsky DK; Yin XM
J Biol Chem; 2000 Dec; 275(50):39474-81. PubMed ID: 10982793
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis.
Grubb DR; Ly JD; Vaillant F; Johnson KL; Lawen A
Oncogene; 2001 Jul; 20(30):4085-94. PubMed ID: 11494136
[TBL] [Abstract][Full Text] [Related]
17. Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis.
Decker RH; Wang S; Dai Y; Dent P; Grant S
Cancer Biol Ther; 2002; 1(2):136-44. PubMed ID: 12170773
[TBL] [Abstract][Full Text] [Related]
18. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
19. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
Rosato RR; Almenara JA; Cartee L; Betts V; Chellappan SP; Grant S
Mol Cancer Ther; 2002 Feb; 1(4):253-66. PubMed ID: 12467221
[TBL] [Abstract][Full Text] [Related]
20. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2.
Murphy KM; Streips UN; Lock RB
Oncogene; 1999 Oct; 18(44):5991-9. PubMed ID: 10557088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
